Skip to main content

Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Important Safety Information

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies

Acute Therapy
Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.
Peritoneal Dialysis
Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.
Hemodialysis
Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.
HDx Therapy
HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Acute Therapy

PrisMax System

Peritoneal Dialysis

Homechoice Claria
Amia
Kaguya
Sharesource

Hemodialysis

Data & Insights

Groundbreaking research and inspirational patient stories.

Clinical Data
Explore the research enabling innovative Renal Care.
Stories
Patients’ journeys inspire our work and drive our commitment.
Resource Library
Access resources for Baxter’s broader Renal Care portfolio.

Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Important Safety Information

SoftPac Citrate and SelectBag Citrate

Suitable for every patient

Brochure

#1

Improved hemodynamic stability may result in fewer episodes of arterial hypotension^1*

#2

Improved control of acid-base balance may reduce adverse effect such as cardiac arrhythmia^2*

#3

Decreased thrombogenicity may allow a reduction of heparin dose^3* and optimizing dialyzer clearances^4,5,6*

#4

Biocompatible alternative to acetate most likely resulting in less adverse effects for the patients in a vitro study^7*

RenalCare Citrate Dialysis Fluid

Citrate dialysis fluid

The Baxter SoftPac Citrate and SelectBag Citrate concentrate allows for acetate-free dialysis fluids which may help to promote patient well-being with all the beneficial properties of Citrate.^8*

Renal Care SelectBag Citrate for hemodialysis

SelectBag Citrate

SelectBag Citrate is an acetate-free concentrate with all the beneficial properties of citrate. With the BiCart Select Citrate system it is easy to optimize the dialysis fluid composition. Sodium and bicarbonate levels are accurately controlled to your settings while the SelectBag Citrate concentrate allows you to easily vary potassium, calcium and glucose.

Download datasheet

Renal Care Select Bag Citrate

SoftPac Citrate

SoftPac Citrate is an acetate-free Concentrate with all the beneficial properties of citrate. The PVC free SoftPac Citrate concentrate is available in two sizes, a 3.5L and 5L bag.

Download datasheet

Related Products

Important Safety Information

For safe and proper use of products mentioned herein, please refer to the appropriate Operators Manual or Instructions for Use.

*Compared to concentrate containing acetate

References

de Sequera P, Garciaa R P, Molina M et al. Prospective randomized multicenter study to demonstrate the benefits of haemodialysis without acetate (with citrate):ABC-treat Study. Acute effect of citrate. Nefrologia 2019; 39(4): 424-433.
De Sequera Ortiz P, Albalate Ramon M et al. Acute effect of citrate bath on postdialysis alkalaemia. Nefrologia 2015; 35:164-71.
Meijers B., Christoph Metalidis C. et al. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study. Nephrol Dial Transplant 2017; 32: 707–714
Grundstrom G, Christensson A, Alquist M et al. Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility. BMC Nephrol 2013, 14:216.
Dellepiane S, Medica D., Guarena C et al. Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvascular injury. Sci Rep 2019; 9: 10622
Molina Nunez M, de Alarcon R et al. Citrate versus Acetate-Based Dialysate in On-Line Haemodiafiltration. A Prospective Cross-Over Study. Blood Purif 2015; 39:181–187.
Huang S, Sandholm K, Jonsson N et al. Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood. Clin Kidney J 2015; 8: 31-37.
Bryland A, Wieslander A, Carlsson O et al. Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions. Diab Vasc Dis Res 2012; 9(1): 42-51.